Michael Pichichero, MD believes that, too often, great science in pediatric infectious disease does not receive the funding by the National Institutes of Health or large charitable foundations that it…
As we head into summer, I’m asking each of us to think about our goals for PIDS this year. My hope is that by intentionally crafting both a shared vision…
Medpage Today reports on an expert panel recently asserting antibiotic resistance will be an expanding threat over time. Bacteria evolving beyond the efficacy of antibiotics, according to the CDC, has…
Reporting on a study from Washington University School of Medicine in St. Louis and The Pew Charitable Trusts, Medical Xpress shares the cost of inappropriately prescribed antibiotics to children cost…
Gabriela Maron, MD, MS, is an Associate Member of the Infectious Diseases Department at St. Jude Children’s Research Hospital and Assistant Professor of Pediatrics at the University of Tennessee Health…
NBC News reports the European Center for Disease Prevention and Control announced the worldwide number of mysterious pediatric hepatitis cases has reached 450 in total from 25 different countries. The…
Medical Xpress covers a report by researchers at Johns Hopkins Children’s Center and elsewhere on the practice of blood draws on PICU patients with fevers and fears of sepsis. To…
Roberto P. Santos is a professor of pediatrics at the University of Mississippi Medical Center and an attending pediatric infectious diseases physician at the Children’s of Mississippi. He currently heads…
PIDS was one of 20 organizations to sign on to the Council of Pediatric Subspecialties (CoPS) policy brief concerning Legislative Priorities for Developing the Next Generation of Diverse Child Health…
I’ve always had a soft spot for idioms and maxims. My dad’s go-to phrase was “well, if a frog had wings, it wouldn’t bump its butt every time it hopped.”…
In a story by Reuters, data from UNICEF and WHO show cases of measles jumped 79% in the first two months of 2022 compared to 2021. Reported cases for January…
CNN reports on the FDA announcement concerning the COVID-19 drug remdesivir and its expanded approval to children younger than 12. Sold under the name Veklury, the drug had been approved…